Clovis Oncology, Inc. (NASDAQ: CLVS) announced tha
Post# of 22755
Posted On: 04/12/2016 8:59:50 AM
Clovis Oncology, Inc. (NASDAQ: CLVS) announced that NASDAQ has halted trading of the Company’s common stock. The U.S. Food and Drug Administration’s (FDA) Oncologic Drugs Advisory Committee (ODAC) is meeting this morning to discuss the company’s New Drug Application (NDA) for rociletinib for the treatment of patients with mutant epidermal growth factor receptor (EGFR) non-small cell lung cancer (NSCLC) who have been previously treated with an EGFR-targeted therapy and have the EGFR T790M mutation.
(0)
(0)
Here We Go!!!!
Scroll down for more posts ▼